Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology
- PMID: 12395312
- DOI: 10.1053/jhep.2002.37084
Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology
Comment on
-
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.Hepatology. 2002 Nov;36(5):1206-13. doi: 10.1053/jhep.2002.36780. Hepatology. 2002. PMID: 12395331
-
Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.Hepatology. 2002 Nov;36(5):1214-20. doi: 10.1053/jhep.2002.36366. Hepatology. 2002. PMID: 12395332
Similar articles
-
[Hepatocarcinoma, liver cirrhosis and the HBV].Rev Clin Esp. 1993 Apr;192(7):305-7. Rev Clin Esp. 1993. PMID: 8388573 Review. Spanish. No abstract available.
-
[Hepatitis B and primary cancer of the liver: recent data on the role of B virus in oncogenesis].Pathol Biol (Paris). 1991 Feb;39(2):157-60. Pathol Biol (Paris). 1991. PMID: 1850121 Review. French.
-
Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.Cancer Surv. 1986;5(4):765-80. Cancer Surv. 1986. PMID: 3040243 Review.
-
[Hepatitis B virus and hepatocellular carcinoma: the track of chromosome X].Gastroenterol Clin Biol. 1993;17(4):314-6. Gastroenterol Clin Biol. 1993. PMID: 8393413 French. No abstract available.
-
The hepatitis-B virus and hepatocellular carcinoma.Semin Liver Dis. 1981 Feb;1(1):59-67. doi: 10.1055/s-2008-1063930. Semin Liver Dis. 1981. PMID: 6287644 Review. No abstract available.
Cited by
-
An indel polymorphism in the 3' untranslated region of JAK1 confers risk for hepatocellular carcinoma possibly by regulating JAK1 transcriptional activity in a Chinese population.Oncol Lett. 2018 May;15(5):8088-8094. doi: 10.3892/ol.2018.8347. Epub 2018 Mar 26. Oncol Lett. 2018. PMID: 29731916 Free PMC article.
-
Targeted therapy for hepatocellular carcinoma.Nat Rev Gastroenterol Hepatol. 2009 Jul;6(7):423-32. doi: 10.1038/nrgastro.2009.86. Epub 2009 Jun 2. Nat Rev Gastroenterol Hepatol. 2009. PMID: 19488072 Review.
-
HBV suppresses thapsigargin-induced apoptosis via inhibiting CHOP expression in hepatocellular carcinoma cells.Oncol Lett. 2017 Oct;14(4):4403-4409. doi: 10.3892/ol.2017.6666. Epub 2017 Jul 25. Oncol Lett. 2017. PMID: 28943956 Free PMC article.
-
Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study.Oncol Lett. 2016 Jan;11(1):624-632. doi: 10.3892/ol.2015.3958. Epub 2015 Nov 23. Oncol Lett. 2016. PMID: 26870257 Free PMC article.
-
Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations.PLoS One. 2013;8(1):e55169. doi: 10.1371/journal.pone.0055169. Epub 2013 Jan 24. PLoS One. 2013. PMID: 23359823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical